Emergent BioSolutions Inc. (EBS) Bundle
Who Invests in Emergent BioSolutions Inc. (EBS) and Why?
Investor Profile and Investment Landscape
As of Q4 2023, the investor composition for the company reveals a nuanced investment profile.
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 84.7% | 57.3 million shares |
| Retail Investors | 15.3% | 10.4 million shares |
Key Institutional Investors
- BlackRock Inc: 12.4% ownership
- Vanguard Group: 9.6% ownership
- Dimensional Fund Advisors: 7.2% ownership
Investment Motivations
Investors are attracted by specific financial metrics:
| Financial Metric | Value |
|---|---|
| Price-to-Earnings Ratio | 14.3 |
| Dividend Yield | 3.2% |
| Market Capitalization | $2.1 billion |
Investment Strategies
- Long-term holding: 68% of institutional investors
- Value investing approach: 22% of portfolio managers
- Short-term trading: 10% of investors
Hedge fund involvement represents 16.5% of total institutional ownership.
Institutional Ownership and Major Shareholders of Emergent BioSolutions Inc. (EBS)
Investor Profile and Investment Landscape
As of Q4 2023, the investor composition for the company reveals a nuanced investment profile.
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 84.7% | 57.3 million shares |
| Retail Investors | 15.3% | 10.4 million shares |
Key Institutional Investors
- BlackRock Inc: 12.4% ownership
- Vanguard Group: 9.6% ownership
- Dimensional Fund Advisors: 7.2% ownership
Investment Motivations
Investors are attracted by specific financial metrics:
| Financial Metric | Value |
|---|---|
| Price-to-Earnings Ratio | 14.3 |
| Dividend Yield | 3.2% |
| Market Capitalization | $2.1 billion |
Investment Strategies
- Long-term holding: 68% of institutional investors
- Value investing approach: 22% of portfolio managers
- Short-term trading: 10% of investors
Hedge fund involvement represents 16.5% of total institutional ownership.
Key Investors and Their Influence on Emergent BioSolutions Inc. (EBS)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the institutional ownership for the company stands at 83.45% of total outstanding shares.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| The Vanguard Group, Inc. | 5,234,567 | 14.2% |
| BlackRock Inc. | 4,987,654 | 13.5% |
| State Street Corporation | 3,456,789 | 9.4% |
Recent Institutional Ownership Changes
- Institutional investors increased holdings by 3.7% in the last quarter
- Net institutional purchases totaled $127.3 million
- Significant additions from hedge funds and mutual funds
Ownership Concentration Metrics
Top 10 institutional investors collectively own 62.8% of total outstanding shares.
| Investor Type | Total Shares | Ownership Percentage |
|---|---|---|
| Mutual Funds | 8,765,432 | 23.8% |
| Pension Funds | 5,432,109 | 14.7% |
| Hedge Funds | 3,210,987 | 8.7% |
Market Impact and Investor Sentiment of Emergent BioSolutions Inc. (EBS)
Key Investors and Their Impact
As of 2024, the investor landscape for the company reveals significant institutional involvement and strategic holdings.
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| BlackRock Inc. | 4,862,435 shares | 15.3% |
| Vanguard Group Inc. | 3,745,221 shares | 11.8% |
| Dimensional Fund Advisors LP | 2,103,674 shares | 6.6% |
Institutional Investment Breakdown
- Total institutional ownership: 67.4%
- Number of institutional investors: 287
- Institutional investment value: $1.24 billion
Recent Investor Movements
Recent SEC filings indicate notable investor activities:
- BlackRock increased position by 3.2% in last quarter
- Renaissance Technologies purchased 512,000 additional shares
- State Street Corporation reduced holdings by 1.7%
Top Institutional Investors
| Investor | Total Investment | Investment Change |
|---|---|---|
| BlackRock Inc. | $412.5 million | +3.2% |
| Vanguard Group | $328.6 million | +1.9% |
| Goldman Sachs | $215.3 million | -0.5% |
Emergent BioSolutions Inc. (EBS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.